Chemotherapy Response in a Mouse Model of Glioma
Author Information
Author(s): R. Bradford, J.L. Darling, D.G.T. Thomas
Primary Institution: Institute of Neurology, Queen Square, London
Hypothesis
The study investigates the effectiveness of various cytotoxic drugs on a murine model of human glioma.
Conclusion
BCNU and CCNU significantly increased survival in mice with glioma, while procarbazine was ineffective.
Supporting Evidence
- BCNU and CCNU produced significant volume reduction in tumors.
- Procarbazine was ineffective in treating glioma in the study.
- BCNU increased median survival significantly compared to control.
- CCNU also increased survival but was less effective than BCNU.
Takeaway
Researchers tested different cancer drugs on mice with brain tumors to see which ones worked best, and found that some drugs helped the mice live longer.
Methodology
The study used a murine model with subcutaneous and intracerebral tumors to evaluate the effects of BCNU, CCNU, vincristine, and procarbazine.
Potential Biases
Potential variability in drug response among different tumor subpopulations.
Limitations
The model may not fully replicate human glioma responses, and no long-term survivors were observed.
Participant Demographics
VM mice, derived from six breeding pairs.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website